thrombocytopenia


Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.

throm·bo·cy·to·pe·ni·a

 (thrŏm′bə-sī′tə-pē′nē-ə)
n.
An abnormally low level of platelets in the circulating blood.
throm′bo·cy′to·pe′nic adj.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

thrombocytopenia

(ˌθrɒmbəʊˌsaɪtəʊˈpiːnɪə)
n
(Pathology) pathol an abnormal decrease in the number of platelets in the blood
[C20: from German thrombocytopenie from thrombocyte + Greek penia poverty]
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014

throm•bo•cy•to•pe•ni•a

(ˌθrɒm boʊˌsaɪ təˈpi ni ə)

n.
an abnormal decrease in the number of blood platelets.
[1920–25]
Random House Kernerman Webster's College Dictionary, © 2010 K Dictionaries Ltd. Copyright 2005, 1997, 1991 by Random House, Inc. All rights reserved.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.thrombocytopenia - a blood disease characterized by an abnormally small number of platelets in the blood
thrombopenia
blood disease, blood disorder - a disease or disorder of the blood
essential thrombocytopenia - the primary form of thrombocytopenia (rather than a shortage of platelets caused by other conditions such as tuberculosis or chemical suppression of bone marrow etc.)
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
Translations
trombocitopénia

throm·bo·cy·to·pe·ni·a

n. trombocitopenia, disminución anormal del número de las plaquetas sanguíneas.
English-Spanish Medical Dictionary © Farlex 2012

thrombocytopenia

n trombocitopenia; immune — (ITP) trombocitopenia inmune (TPI)
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
Mentioned in ?
References in periodicals archive ?
(Alliance News) - Hutchison China Meditech Ltd on Friday said it has begun a phase 1 study of HMPL-523 as a treatment for immune thrombocytopenia in China, dosing the first patient on Monday last week.
Hutchison China Meditech Starts HMPL-523 Trial In China
Dova is a pharmaceutical company focused on acquiring, developing, and commercializing drug candidates for diseases where there is a high unmet need, with an initial focus on addressing thrombocytopenia. Dova's proprietary pipeline includes one commercial product, DOPTELET, for the treatment of thrombocytopenia in adult patients with chronic liver disease scheduled to undergo a procedure and the treatment of thrombocytopenia in adults with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment.
Dova Pharmaceuticals to Present at 2019 Wedbush PacGrow Healthcare Conference
"The last few months have been a transformational period in Dova's history, with FDA approval and launch of our thrombopoietin receptor agonist DOPTELET for ITP, European approval of DOPTELET for severe thrombocytopenia in adult patients with CLD, and an expanded co-promotion partnership with Salix for CLD.
Dova Pharmaceuticals reports Q2 EPS (60c), consensus (57c)
Studies have indicated that various haematological abnormalities like anaemia, thrombocytopenia, atypical lymphocytosis, rarely disseminated intravascular coagulation (DIC) are associated with malaria.
HAEMATOLOGICAL PROFILE IN MALARIA WITH SPECIAL REFERENCE TO THROMBOCYTOPENIA
This collaboration is an important milestone for patients in China living with chronic liver disease, bringing a well-tolerated and effective treatment option for severe thrombocytopenia that facilitates the management of invasive procedures one step closer to these patients.", said Dr.
Japan Pharmaceuticals Industry - Shionogi Concludes Licensing Agreements with Eddingpharm for Lusutrombopag, a Thrombopoietin Receptor Agonist -- 24/6/2019
Severe fever with thrombocytopenia syndrome virus (SFTSV) is a tickborne virus (genus Phlebovirus, family Phenuiviridae) that can cause a mild to severe febrile illness similar to hemorrhagic fever (1).
Endemic Severe Fever with Thrombocytopenia Syndrome, Vietnam
KEYWORDS: Thrombocytopenia, Intensive care unit, Pathogenesis, Management.
Thrombocytopenia in the intensive care unit
M2 EQUITYBITES-December 17, 2018-Amgen awarded the US FDA approval for Nplate (Romiplostim) for the treatment of immune thrombocytopenia in paediatric patients
Amgen awarded the US FDA approval for Nplate (Romiplostim) for the treatment of immune thrombocytopenia in paediatric patients
Global Banking News-December 17, 2018-Amgen awarded the US FDA approval for Nplate (Romiplostim) for the treatment of immune thrombocytopenia in paediatric patients
Amgen awarded the US FDA approval for Nplate (Romiplostim) for the treatment of immune thrombocytopenia in paediatric patients
M2 PHARMA-December 17, 2018-Amgen awarded the US FDA approval for Nplate (Romiplostim) for the treatment of immune thrombocytopenia in paediatric patients
Amgen awarded the US FDA approval for Nplate (Romiplostim) for the treatment of immune thrombocytopenia in paediatric patients
Thrombocytopenia after allogeneic peripheral stem cell transplantation is a very common complication (1).
Use of Eltrombopag in Patients with Platelet Engraftment Failure Following Second Allogeneic Peripheral Stem Cell Transplantation
[ClickPress, Thu Sep 27 2018] Immune Thrombocytopenia is an autoimmune disorder that results in an abnormally low level of platelets.
Immune Thrombocytopenia Treatment Market: Global Industry Trend Analysis 2013 to 2017 and Forecast 2

Dictionary browser ?
Full browser ?